Abstract: Dental compositions that comprise algae are disclosed. Methods of use of the dental compositions, including methods of reducing plaque on at least one tooth of an animal using the dental compositions, are also disclosed.
Abstract: This invention relates to systems, methods, and devices for inducing andlor repressing the expression of proteins. More particularly, the invention relates to systems, methods, and devices for inducing andlor repressing the expression of proteins in plastids. An exemplary embodiment involves the regulation of the expression of proteins involved in hydrogen production to stimulate the production of hydrogen gas using the methods, systems, and devices described herein.
Type:
Grant
Filed:
September 10, 2018
Date of Patent:
March 9, 2021
Assignee:
SOLARVEST BIOENERGY INC.
Inventors:
Richard E. Wagner, Raymond Surzycki, Jean-David Rochaix
Abstract: The present disclosure provides a modified cecropin protein comprising a cecropin or a variant thereof fused to a hydrophilic tail lacking a C-terminal glycine. The present disclosure also provides pharmaceutical compositions, methods and uses of the modified cecropin protein or nucleic acid for treating or preventing endoparasites, such as Plasmodium, and bacteria.
Type:
Grant
Filed:
July 13, 2012
Date of Patent:
December 27, 2016
Assignee:
SOLARVEST BIOENERGY INC.
Inventors:
Subrata Chowdhury, Michael Thomas Horne
Abstract: This invention relates to systems, methods, and devices for inducing and/or repressing the expression of proteins. More particularly, the invention relates to systems, methods, and devices for inducing and/or repressing the expression of proteins in plastids. An exemplary embodiment involves the regulation of the expression of proteins involved in hydrogen production to stimulate the production of hydrogen gas using the methods, systems, and devices described herein.
Type:
Grant
Filed:
August 11, 2007
Date of Patent:
January 5, 2016
Assignee:
Solarvest Bioenergy Inc.
Inventors:
Raymond Surzycki, Jean-David Rochaix, Richard E. Wagner
Abstract: The present disclosure provides a modified cecropin protein comprising a cecropin or a variant thereof fused to a hydrophilic tail lacking a C-terminal glycine. The present disclosure also provides pharmaceutical compositions, methods and uses of the modified cecropin protein or nucleic acid for treating or preventing endoparasites, such as Plasmodium, and bacteria.
Type:
Application
Filed:
July 13, 2012
Publication date:
June 19, 2014
Applicant:
SOLARVEST BIOENERGY INC.
Inventors:
Subrata Chowdhury, Michael Thomas Horne
Abstract: Delivery systems and methods are provided for delivering a biologically active protein to a host animal. The systems and methods provided include obtaining an algal cell transformed by an expression vector, the expression vector comprising a nucleotide sequence coding for the biologically active protein, operably linked to a promoter. In one illustrated embodiment, the biologically active protein is an antigenic epitope and upon administration to the animal the algal cell induces an immune response in the host animal.
Type:
Application
Filed:
May 28, 2013
Publication date:
May 8, 2014
Applicants:
The Ohio State University, Solarvest BioEnergy Inc.
Inventors:
Richard T. Sayre, Richard E. Wagner, Surasak Siripornadulsil, Carlos Farias